Tivic Health Receives Approval from Institutional Review Board for ncVNS Optimization Study, Readies for Enrollment
SAN FRANCISCO – (Business Wire) – September 18, 2024 – Tivic Health® Systems, Inc. (“Tivic Health”, Nasdaq:
Tivic Health Systems, Inc. is a commercial-stage bioelectronic medicine company focused on treating diseases and conditions by modulating the electrical signals carried along various nerve pathways.
Our first FDA-approved product, ClearUP® Sinus Pain Relief (“ClearUP”), is a patented handheld device that uses ultra-low current electrical waves to relieve sinus pain and congestion, common symptoms of sinus and nasal inflammation. These symptoms are often associated with nasal allergies, sinus infections, chronic sinusitis, cold and flu, a $9.9 billion U.S. market currently dominated by pharmaceutical companies. ClearUP, a non-invasive bioelectronic therapy, can safely and comfortably deliver therapeutic benefits with no significant side effects.
ClearUP is a US FDA Class II and EU Class IIa medical device that has received three regulatory clearances: (US FDA 510(k) number K182025, US FDA De Novo number DEN200006 and EU CE Mark Certificate number CE 704687). ClearUP is available on Amazon, Best Buy, Walgreens, Walmart and other major e-commerce websites.
SAN FRANCISCO – (Business Wire) – September 18, 2024 – Tivic Health® Systems, Inc. (“Tivic Health”, Nasdaq:
Partners with leading growth strategy firm, Fletcher Spaght SAN FRANCISCO – (Business Wire) – September 17,
Kimberly Bambach, Ms. Wolf’s predecessor, continues with Tivic as advisor focused on strategic transactions and
On May 13, 2022, Tivic Health Systems’ held its second shareholder update conference call. Tivic’s Chief Executive Officer, Jennifer Ernst, presented the Q1 2022 results of operations and the company’s progress since its IPO last November.
Hanover International
Jim Hock
Email: ir@tivichealth.com
Equiniti Trust Company (EQ)
Customer Care Center
(800) 468-9716 or (651) 450-4064
1110 Centre Point Curve, Suite 101
Mendota Heights, MN 55120-4100
P.O. Box 64874
St. Paul, MN 55164-0874
Sheryle Bolton, Chairperson
Karen Drexler
Christina Valauri
Dean Zikria
Karen Drexler, Chairperson
Sheryle Bolton
Christina Valauri
Dean Zikria
Christina Valauri, Chairperson
Karen Drexler
Sheryle Bolton
Dean Zikria
Stay in the know with all things Tivic.